Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Borentain

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Clinics and Research in Hepatology and Gastroenterology|July 23, 2019
Chronic hepatitis E in absence of severe immune deficiencyPhilippe Colson, Nicolas Schleinitz, Frédéric Vely, et al.
Future Microbiology|May 3, 2024
A catalog of ethanol-producing microbes in humansBabacar Mbaye, Reham Magdy Wasfy, Maryam Tidjani Alou, et al.
Gastroenterologie Clinique Et Biologique|March 4, 2006
[Budd-Chiari syndrome with medullar compression]Patrick Borentain, Bénédicte Mugnier, Carlos Barrantes, et al.
The Journal of Infectious Diseases|August 11, 2010
Pig liver sausage as a source of hepatitis E virus transmission to humansPhilippe Colson, Patrick Borentain, Benjamin Queyriaux, et al.
Journal of Hepatology|August 13, 2013
Assessment of chronic rejection in liver graft recipients receiving immunosuppression with low-dose calcineurin inhibitorsLouise Barbier, Stéphane Garcia, Jérôme Cros, et al.
Clinics and Research in Hepatology and Gastroenterology|November 5, 2013
Impact of transjugular intrahepatic portosystemic shunting on liver transplantation: 12-year single-center experienceLouise Barbier, Jean Hardwigsen, Patrick Borentain, et al.
Oncotarget|December 6, 2019
A squalamine derivative, NV669, as a novel PTP1B inhibitor: <i>in vitro</i> and <i>in vivo</i> effects on pancreatic and hepatic tumor growthSylvie Carmona, Jean-Michel Brunel, Rénaté Bonier, et al.
Gastroenterologie Clinique Et Biologique|March 28, 2006
[High serum alkaline phosphatase level revealing a liver adenoma]Patrick Borentain, René Gérolami, Franck Dodero, et al.
Intervirology|January 17, 2015
Hepatitis C virus of subtype 2l in Marseille, southeastern FranceSarah Aherfi, Olga Glazunova, Patrick Borentain, et al.
International Journal of Cancer|June 23, 2007
Introducing alpha(1,2)-linked fucose into hepatocarcinoma cells inhibits vasculogenesis and tumor growthSylvie Mathieu, René Gerolami, José Luis, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Clinics and Research in Hepatology and Gastroenterology|July 23, 2019
Chronic hepatitis E in absence of severe immune deficiencyPhilippe Colson, Nicolas Schleinitz, Frédéric Vely, et al.
Future Microbiology|May 3, 2024
A catalog of ethanol-producing microbes in humansBabacar Mbaye, Reham Magdy Wasfy, Maryam Tidjani Alou, et al.
Gastroenterologie Clinique Et Biologique|March 4, 2006
[Budd-Chiari syndrome with medullar compression]Patrick Borentain, Bénédicte Mugnier, Carlos Barrantes, et al.
The Journal of Infectious Diseases|August 11, 2010
Pig liver sausage as a source of hepatitis E virus transmission to humansPhilippe Colson, Patrick Borentain, Benjamin Queyriaux, et al.
Journal of Hepatology|August 13, 2013
Assessment of chronic rejection in liver graft recipients receiving immunosuppression with low-dose calcineurin inhibitorsLouise Barbier, Stéphane Garcia, Jérôme Cros, et al.
Clinics and Research in Hepatology and Gastroenterology|November 5, 2013
Impact of transjugular intrahepatic portosystemic shunting on liver transplantation: 12-year single-center experienceLouise Barbier, Jean Hardwigsen, Patrick Borentain, et al.
Oncotarget|December 6, 2019
A squalamine derivative, NV669, as a novel PTP1B inhibitor: <i>in vitro</i> and <i>in vivo</i> effects on pancreatic and hepatic tumor growthSylvie Carmona, Jean-Michel Brunel, Rénaté Bonier, et al.
Gastroenterologie Clinique Et Biologique|March 28, 2006
[High serum alkaline phosphatase level revealing a liver adenoma]Patrick Borentain, René Gérolami, Franck Dodero, et al.
Intervirology|January 17, 2015
Hepatitis C virus of subtype 2l in Marseille, southeastern FranceSarah Aherfi, Olga Glazunova, Patrick Borentain, et al.
International Journal of Cancer|June 23, 2007
Introducing alpha(1,2)-linked fucose into hepatocarcinoma cells inhibits vasculogenesis and tumor growthSylvie Mathieu, René Gerolami, José Luis, et al.
Pageof 7